IGI Laboratories Inc. v. Mallinckrodt LLC
1:13-cv-02044
Overview
Parties
Defendant
Nuvo Research Inc. Operating Company
Represented By
2 Attorneys ListedRichards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Richards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Mallinckrodt Inc. Operating Company
Represented By
2 Attorneys ListedRichards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Richards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Mallinckrodt LLC Operating Company
Represented By
2 Attorneys ListedRichards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Richards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Plaintiff
IGI Laboratories Inc. Operating Company
Represented By
4 Attorneys ListedGreenberg Traurig, LLP
The Nemours Building, 1007 North Orange Street, Suite 1200
Seitz Ross Aronstam & Moritz LLP
100 S. West Street, Suite 400, Wilmington, DE 19801
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 4 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | Asserted | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → |
HORIZON PHARMA IRELAND LIMITED v. ACTAVIS LABORATORIES, UT, INC.
Mallinckrodt LLC v. Taro Pharmaceutical Industries Ltd.
Patents Involved
There are 2 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US8217078
Treatment of pain with topical diclofenac
|
Filed: 2010-10-28
Issued: 2012-07-10
|
Active (3.9 yrs remaining)
Expires: 2030-10-28
|
|
|
US8546450
Treatment of pain with topical diclofenac compounds
|
Filed: 2009-07-10
Issued: 2013-10-01
|
Active (3.7 yrs remaining)
+395d PTA
Expires: 2030-08-09
|
Patent Enforceability & Injunction Risk Assessment
Active Threat β Patent is within enforceable statutory term; injunctive relief viable.
Standard Statutory Term β No obviousness-type double patenting noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).
Procedural Motions & Interlocutory Orders
Total Motions
14
Dispositive
9
Granted
1
Denied
0
Pending / Review
11
Motions by Category
Key Dispositive Motions & Rulings